BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23267874)

  • 1. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
    Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
    Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
    Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
    Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature.
    Tekin B; Yücelten AD
    Pediatr Dermatol; 2015; 32(5):723-6. PubMed ID: 26119800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bullous pemphigoid: a review].
    Bernard P; Charneux J
    Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
    Xiao T; Li B; Wang YK; He CD; Chen HD
    J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory childhood pemphigoid successfully treated with rituximab.
    Fuertes I; Luelmo J; Leal L; Romaní J; Sánchez S; Mascaró JM
    Pediatr Dermatol; 2013; 30(5):e96-7. PubMed ID: 23278674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy.
    Watanabe T; Hara S; Muto J; Watanabe D; Akiyama M
    Clin Exp Dermatol; 2017 Jul; 42(5):576-578. PubMed ID: 28543802
    [No Abstract]   [Full Text] [Related]  

  • 9. Bullous pemphigoid treated with intravenous immunoglobulin.
    Tuchinda P; Ritchie S; Gaspari AA
    Cutis; 2014 May; 93(5):264-8. PubMed ID: 24897141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
    Nigam R; Levitt J
    J Drugs Dermatol; 2012 May; 11(5):622-5. PubMed ID: 22527431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory bullous pemphigoid with fatal outcome in a young patient.
    Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
    Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
    Nguyen T; Ahmed AR
    Clin Exp Dermatol; 2017 Jul; 42(5):516-519. PubMed ID: 28508388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
    Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
    [No Abstract]   [Full Text] [Related]  

  • 15. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy.
    Sugawara N; Nagai Y; Matsushima Y; Aoyama K; Ishikawa O
    J Am Acad Dermatol; 2007 Dec; 57(6):1084-9. PubMed ID: 17889964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid.
    Gaitanis G; Alexis I; Pelidou SH; Gazi IF; Kyritsis AP; Elisaf MS; Bassukas ID
    Eur J Dermatol; 2012; 22(3):363-9. PubMed ID: 22548754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for bullous pemphigoid.
    Kirtschig G; Middleton P; Bennett C; Murrell DF; Wojnarowska F; Khumalo NP
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD002292. PubMed ID: 20927731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe bullous pemphigoid in an infant--successful treatment with rituximab.
    Schulze J; Bader P; Henke U; Rose MA; Zielen S
    Pediatr Dermatol; 2008; 25(4):462-5. PubMed ID: 18789089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.
    Seidling V; Hoffmann JH; Enk AH; Hadaschik EN
    Acta Derm Venereol; 2013 May; 93(3):346-9. PubMed ID: 23073990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin.
    Ister M; Pouessel G; Ythier H; Catteau B; Carpentier O
    Pediatr Dermatol; 2014; 31(4):e94-5. PubMed ID: 24916151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.